Cargando…

Phosphoethanolamine Transferases as Drug Discovery Targets for Therapeutic Treatment of Multi-Drug Resistant Pathogenic Gram-Negative Bacteria

Antibiotic resistance caused by multidrug-resistant (MDR) bacteria is a major challenge to global public health. Polymyxins are increasingly being used as last-in-line antibiotics to treat MDR Gram-negative bacterial infections, but resistance development renders them ineffective for empirical thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thai, Van C., Stubbs, Keith A., Sarkar-Tyson, Mitali, Kahler, Charlene M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525099/ https://www.ncbi.nlm.nih.gov/pubmed/37760679 http://dx.doi.org/10.3390/antibiotics12091382

Ejemplares similares

Novel small molecules that increase the susceptibility of Neisseria gonorrhoeae to cationic antimicrobial peptides by inhibiting lipid A phosphoethanolamine transferase
por: Mullally, Christopher, et al.
Publicado: (2022)

The Role of Oxidoreductases in Determining the Function of the Neisserial Lipid A Phosphoethanolamine Transferase Required for Resistance to Polymyxin
por: Piek, Susannah, et al.
Publicado: (2014)

Phosphoethanolamine and the danger of unproven drugs
por: Pondé, Noam, et al.
Publicado: (2016)

Structure-Function Relationships of the Neisserial EptA Enzyme Responsible for Phosphoethanolamine Decoration of Lipid A: Rationale for Drug Targeting
por: Kahler, Charlene M., et al.
Publicado: (2018)

Bifurcation kinetics of drug uptake by Gram-negative bacteria
por: Westfall, David A., et al.
Publicado: (2017)

Activity of siderophores against drug-resistant Gram-positive and Gram-negative bacteria
por: Gokarn, Karuna, et al.
Publicado: (2018)

Biosynthesis of Osmoregulated Periplasmic Glucans in Escherichia coli: The Phosphoethanolamine Transferase Is Encoded by opgE
por: Bontemps-Gallo, Sébastien, et al.
Publicado: (2013)

Exogenous and Endogenous Phosphoethanolamine Transferases Differently Affect Colistin Resistance and Fitness in Pseudomonas aeruginosa
por: Cervoni, Matteo, et al.
Publicado: (2021)

Novel Fluoroquinolones with Possible Antibacterial Activity in Gram-Negative Resistant Pathogens: In Silico Drug Discovery
por: Coba-Males, Manuel Alejandro, et al.
Publicado: (2023)

Novel Immunization Strategies Against Multi-drug-resistant Gram-negative Bacteria
por: Youssef, Eman A, et al.
Publicado: (2017)

Screening for multi-drug-resistant Gram-negative bacteria: what is effective and justifiable?
por: Nijsingh, Niels, et al.
Publicado: (2020)

Crystal Structure of Escherichia coli originated MCR-1, a phosphoethanolamine transferase for Colistin Resistance
por: Hu, Menglong, et al.
Publicado: (2016)

Regulatory Landscape of the Pseudomonas aeruginosa Phosphoethanolamine Transferase Gene eptA in the Context of Colistin Resistance
por: Cervoni, Matteo, et al.
Publicado: (2023)

Broad-spectrum in vitro activity of macrophage infectivity potentiator inhibitors against Gram-negative bacteria and Leishmania major
por: Iwasaki, Jua, et al.
Publicado: (2022)

Editorial: Bad Bugs in the XXIst Century: Resistance Mediated by Multi-Drug Efflux Pumps in Gram-Negative Bacteria
por: Vargiu, Attilio V., et al.
Publicado: (2016)

Equisetin Restores Colistin Sensitivity against Multi-Drug Resistant Gram-Negative Bacteria
por: Zhang, Qi, et al.
Publicado: (2021)

Veterinary clinic surfaces as reservoirs of multi-drug- and biocide-resistant Gram-negative bacteria
por: Akwuobu, Chinedu A., et al.
Publicado: (2021)

Targeting LPS biosynthesis and transport in gram-negative bacteria in the era of multi-drug resistance
por: Romano, K.P., et al.
Publicado: (2023)

Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria
por: Eichenberger, Emily M., et al.
Publicado: (2019)

Drug development concerning metallo-β-lactamases in gram-negative bacteria
por: Li, Xiuyun, et al.
Publicado: (2022)

Correction: The Role of Oxidoreductases in Determining the Function of the Neisserial Lipid A Phosphoethanolamine Transferase Required for Resistance to Polymyxin
Publicado: (2014)

Functional Identification of Proteus mirabilis eptC Gene Encoding a Core Lipopolysaccharide Phosphoethanolamine Transferase
por: Aquilini, Eleonora, et al.
Publicado: (2014)

Challenges in Drug Discovery for Intracellular Bacteria
por: Tucker, Allison N., et al.
Publicado: (2021)

Multi-scale model of drug induced adaptive resistance of Gram-negative bacteria to polymyxin B
por: Krzyzanski, Wojciech, et al.
Publicado: (2017)

Identification of Putative Drug Targets in Highly Resistant Gram-Negative Bacteria; and Drug Discovery Against Glycyl-tRNA Synthetase as a New Target
por: Fereshteh, Sepideh, et al.
Publicado: (2023)

When it comes to drug discovery not all Gram‐negative bacterial biodefence pathogens are created equal: Burkholderia pseudomallei is different
por: Schweizer, Herbert P.
Publicado: (2012)

Phosphoethanolamine Transferase LptA in Haemophilus ducreyi Modifies Lipid A and Contributes to Human Defensin Resistance In Vitro
por: Trombley, Michael P., et al.
Publicado: (2015)

Docking predictions based Plasmodium falciparum phosphoethanolamine methyl transferase inhibitor identification and in-vitro antimalarial activity analysis
por: Singh, Jagbir, et al.
Publicado: (2019)

Anti-Virulence Therapeutic Approaches for Neisseria gonorrhoeae
por: Lim, Katherine Y. L., et al.
Publicado: (2021)

Infections Caused by Antimicrobial Drug-Resistant Saprophytic Gram-Negative Bacteria in the Environment
por: Raphael, Eva, et al.
Publicado: (2017)

Sulfoxides, Analogues of L-Methionine and L-Cysteine As Pro-Drugs against Gram-Positive and Gram-Negative Bacteria
por: Anufrieva, N. V., et al.
Publicado: (2015)

In Vitro Activity of Cefiderocol against Multi-Drug Resistant Carbapenemase-Producing Gram-Negative Pathogens
por: Boyd, Sandra, et al.
Publicado: (2017)

In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections
por: Gopichand, Pallam, et al.
Publicado: (2019)

Evaluating the Prevalence and the Risk Factors of Gram-Negative Multi-Drug Resistant Bacteria in Eastern Saudi Arabia
por: Al Hamdan, Aisha S, et al.
Publicado: (2022)

Computational and experimental elucidation of Plasmodium falciparum phosphoethanolamine methyltransferase inhibitors: Pivotal drug target
por: Singh, Jagbir, et al.
Publicado: (2019)

Bismuth Drugs Reverse Tet(X)-Conferred Tigecycline Resistance in Gram-Negative Bacteria
por: Deng, Tian, et al.
Publicado: (2022)

Data-Driven Derivation of Molecular Substructures That Enhance Drug Activity in Gram-Negative Bacteria
por: Gurvic, Dominik, et al.
Publicado: (2022)

CRISPR-Cas System: A Tool to Eliminate Drug-Resistant Gram-Negative Bacteria
por: Kundar, Rajeshwari, et al.
Publicado: (2022)

Targeting BAM for Novel Therapeutics against Pathogenic Gram-Negative Bacteria
por: Overly Cottom, Claire, et al.
Publicado: (2023)

Bacteriophage as a Novel Therapeutic Weapon for Killing Colistin-Resistant Multi-Drug-Resistant and Extensively Drug-Resistant Gram-Negative Bacteria
por: Mousavi, Seyed Mohammad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ssnmjctjc475ap0iv10hc00531